Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 50 | 2025 | 246 | 12.950 |
Why?
|
| Aortic Valve Stenosis | 43 | 2025 | 378 | 10.890 |
Why?
|
| Heart Valve Prosthesis | 42 | 2025 | 331 | 8.640 |
Why?
|
| Mitral Valve Insufficiency | 22 | 2025 | 185 | 6.450 |
Why?
|
| Heart Valve Prosthesis Implantation | 25 | 2025 | 462 | 5.650 |
Why?
|
| Aortic Valve | 41 | 2025 | 485 | 4.440 |
Why?
|
| Mitral Valve | 18 | 2025 | 270 | 2.420 |
Why?
|
| Cardiac Catheterization | 18 | 2025 | 665 | 1.750 |
Why?
|
| Treatment Outcome | 64 | 2025 | 13016 | 1.680 |
Why?
|
| Prosthesis Design | 25 | 2025 | 669 | 1.660 |
Why?
|
| Bioprosthesis | 5 | 2025 | 119 | 1.430 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2024 | 157 | 1.300 |
Why?
|
| Bundle-Branch Block | 2 | 2020 | 37 | 1.260 |
Why?
|
| Aged, 80 and over | 30 | 2025 | 7111 | 0.950 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2024 | 65 | 0.940 |
Why?
|
| Risk Factors | 38 | 2025 | 10910 | 0.900 |
Why?
|
| Registries | 14 | 2025 | 1585 | 0.890 |
Why?
|
| Percutaneous Coronary Intervention | 6 | 2025 | 304 | 0.870 |
Why?
|
| Multidetector Computed Tomography | 7 | 2025 | 39 | 0.820 |
Why?
|
| Predictive Value of Tests | 12 | 2025 | 2303 | 0.820 |
Why?
|
| Acute Coronary Syndrome | 5 | 2025 | 244 | 0.810 |
Why?
|
| Heart Valve Diseases | 5 | 2025 | 178 | 0.790 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3139 | 0.770 |
Why?
|
| Prosthesis Failure | 5 | 2025 | 162 | 0.720 |
Why?
|
| Hemodynamics | 8 | 2024 | 860 | 0.690 |
Why?
|
| Humans | 82 | 2025 | 132334 | 0.690 |
Why?
|
| Ventricular Septum | 1 | 2020 | 16 | 0.640 |
Why?
|
| Aged | 33 | 2025 | 21379 | 0.630 |
Why?
|
| Calcinosis | 3 | 2024 | 191 | 0.540 |
Why?
|
| Retrospective Studies | 29 | 2025 | 17363 | 0.510 |
Why?
|
| Heart Ventricles | 1 | 2020 | 781 | 0.460 |
Why?
|
| Risk Assessment | 11 | 2025 | 3710 | 0.420 |
Why?
|
| Reoperation | 7 | 2025 | 853 | 0.410 |
Why?
|
| Catheters | 2 | 2024 | 89 | 0.400 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2024 | 19 | 0.380 |
Why?
|
| Prosthesis-Related Infections | 2 | 2024 | 187 | 0.370 |
Why?
|
| Echocardiography | 6 | 2025 | 1125 | 0.370 |
Why?
|
| Balloon Valvuloplasty | 2 | 2021 | 24 | 0.340 |
Why?
|
| Time Factors | 14 | 2025 | 6455 | 0.330 |
Why?
|
| Feasibility Studies | 5 | 2025 | 826 | 0.330 |
Why?
|
| Severity of Illness Index | 7 | 2024 | 3087 | 0.320 |
Why?
|
| Frailty | 2 | 2023 | 135 | 0.310 |
Why?
|
| Male | 31 | 2025 | 65052 | 0.310 |
Why?
|
| Heart Failure | 4 | 2024 | 2386 | 0.300 |
Why?
|
| Female | 29 | 2025 | 70786 | 0.280 |
Why?
|
| Middle Aged | 14 | 2025 | 28888 | 0.270 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 892 | 0.260 |
Why?
|
| Recovery of Function | 6 | 2025 | 461 | 0.260 |
Why?
|
| Endocarditis | 2 | 2024 | 108 | 0.250 |
Why?
|
| Coronary Vessels | 2 | 2020 | 548 | 0.240 |
Why?
|
| Device Removal | 2 | 2024 | 225 | 0.230 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2025 | 16 | 0.230 |
Why?
|
| Off-Label Use | 1 | 2024 | 29 | 0.220 |
Why?
|
| Atrial Pressure | 1 | 2024 | 6 | 0.220 |
Why?
|
| Clinical Decision-Making | 3 | 2024 | 299 | 0.220 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 29 | 0.220 |
Why?
|
| Mercury | 1 | 2024 | 30 | 0.210 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2024 | 55 | 0.210 |
Why?
|
| Heart Valves | 1 | 2024 | 52 | 0.210 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 167 | 0.190 |
Why?
|
| Propensity Score | 1 | 2024 | 255 | 0.190 |
Why?
|
| Computed Tomography Angiography | 2 | 2025 | 215 | 0.190 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 207 | 0.190 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 212 | 0.190 |
Why?
|
| Tricuspid Valve | 1 | 2022 | 62 | 0.190 |
Why?
|
| Aortography | 2 | 2019 | 183 | 0.180 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2022 | 49 | 0.180 |
Why?
|
| Stents | 2 | 2025 | 873 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2024 | 1230 | 0.180 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 26 | 0.180 |
Why?
|
| Survival Rate | 5 | 2025 | 2187 | 0.160 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2019 | 5 | 0.160 |
Why?
|
| Patient Readmission | 2 | 2021 | 423 | 0.160 |
Why?
|
| Health Resources | 1 | 2020 | 129 | 0.150 |
Why?
|
| Organ Size | 1 | 2020 | 447 | 0.150 |
Why?
|
| Incidence | 2 | 2025 | 3361 | 0.150 |
Why?
|
| Outpatients | 1 | 2020 | 275 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2025 | 889 | 0.150 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 16 | 0.140 |
Why?
|
| Myocarditis | 1 | 2019 | 130 | 0.140 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 120 | 0.140 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 88 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2025 | 903 | 0.140 |
Why?
|
| Fluoroscopy | 3 | 2025 | 100 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2019 | 484 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 558 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 569 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2020 | 1454 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1084 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1061 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2025 | 364 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2016 | 228 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2025 | 2169 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2021 | 1076 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 5405 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1829 | 0.080 |
Why?
|
| North America | 2 | 2020 | 265 | 0.080 |
Why?
|
| United States | 5 | 2025 | 11627 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1831 | 0.070 |
Why?
|
| Age Factors | 2 | 2024 | 2931 | 0.070 |
Why?
|
| Texas | 2 | 2025 | 3628 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1247 | 0.060 |
Why?
|
| Patient-Specific Modeling | 1 | 2025 | 9 | 0.060 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2024 | 15 | 0.060 |
Why?
|
| Systole | 1 | 2024 | 201 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 117 | 0.050 |
Why?
|
| Workflow | 1 | 2024 | 134 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 68 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2024 | 443 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2024 | 137 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 5009 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 232 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 237 | 0.050 |
Why?
|
| Thinness | 1 | 2023 | 76 | 0.050 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2022 | 25 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 206 | 0.040 |
Why?
|
| Dilatation | 1 | 2021 | 71 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 656 | 0.040 |
Why?
|
| Steroids | 1 | 2022 | 173 | 0.040 |
Why?
|
| Dobutamine | 1 | 2020 | 56 | 0.040 |
Why?
|
| Milrinone | 1 | 2020 | 30 | 0.040 |
Why?
|
| Radial Artery | 1 | 2020 | 32 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 461 | 0.040 |
Why?
|
| New York | 1 | 2020 | 72 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 534 | 0.040 |
Why?
|
| Health Status | 1 | 2022 | 409 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 471 | 0.040 |
Why?
|
| Overweight | 1 | 2023 | 384 | 0.040 |
Why?
|
| Endocardium | 1 | 2019 | 54 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2020 | 167 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 288 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 65 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2024 | 511 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 373 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 135 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 545 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 9 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2018 | 56 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2021 | 415 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 399 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2019 | 148 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2664 | 0.030 |
Why?
|
| Troponin T | 1 | 2019 | 295 | 0.030 |
Why?
|
| Medicare | 1 | 2021 | 448 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 31618 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 258 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1261 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 9945 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2023 | 1707 | 0.030 |
Why?
|
| Morocco | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2016 | 36 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1288 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 110 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 699 | 0.030 |
Why?
|
| Introns | 1 | 2016 | 304 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 908 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 626 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 362 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 989 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 387 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20552 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2556 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 413 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1894 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2406 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 815 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5150 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1541 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3022 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3421 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3853 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2851 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 13192 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 14851 | 0.010 |
Why?
|
| Child | 1 | 2016 | 25823 | 0.010 |
Why?
|